The Therapeutic Effect of Human Stem Cell Therapy on the Expanded Disability Status Scale Improvement in Multiple Sclerosis

AuthorShahram Darabi
AuthorAli Asghar Keramatinia
AuthorAliye Roosta Tasouji
AuthorSomayeh Niknazar
AuthorNavid Ahmady Roozbahany
AuthorLeila Darabi
AuthorHojjat-allah Abbaszadeh
AuthorFariborz Rashnoo
Accessioned Date2024-05-27T01:31:05Z
Available Date2024-05-27T01:31:05Z
Issued Date2023-09-30
AbstractMultiple Sclerosis (MS) is a central nervous system inflammatory disease in which the myelin sheaths of neurons are damaged. This impairs the ability of the neurons for signal conduction and communication and causes many neurological signs and symptoms. In this study, we evaluated stem cell therapy for multiple sclerosis. We reviewed the scientific literature focusing on stem cell therapy for multiple sclerosis available from 2003 to 2022. This narrative systematic review was performed to evaluate the effect of human stem cell therapy on expanded disability status scale (EDSS) improvement in multiple sclerosis. No time limits were set for the search and all relevant clinical trials were included. The results showed that the rate of recovery of patients with stem cell therapy depends on the rate of stem cell injection and the frequency, the volume of injected cells, and the rate of disease progression. Overall, the survival rate and quality of life increased following the treatment. The expanded disability status scale changed with stem cell injection, but this change was not significant. Most cases experienced an improvement in bladder control. Death or hospitalization after injection and severe allergies were not observed. Our results showed stem cells could increase the quality of life and survival and reduce the incidence of motor symptoms in MS patients.
DOIhttps://doi.org/10.22037/jcma.v8i3.39986
URIhttps://repository.brieflands.com/handle/123456789/59922
Keywordstem cell
KeywordMultiple sclerosis
KeywordSystematic review
Keywordimprovement
PublisherBrieflands
TitleThe Therapeutic Effect of Human Stem Cell Therapy on the Expanded Disability Status Scale Improvement in Multiple Sclerosis
TypeReview
Files